These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 33839960

  • 1. Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.
    Niu MM, Jiang Q, Ruan JW, Liu HH, Chen WX, Qiu Z, Fan GZ, Li RX, Wei W, Hu P.
    Clin Exp Med; 2021 Nov; 21(4):633-643. PubMed ID: 33839960
    [Abstract] [Full Text] [Related]

  • 2. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?
    Dominguez SR, Martin B, Heizer H, Jone PN, Tong S, Davidson J, Anderson MS, Glodé MP.
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):297-302. PubMed ID: 26407256
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.
    Wu Y, Liu FF, Xu Y, Wang JJ, Samadli S, Wu YF, Liu HH, Chen WX, Luo HH, Zhang DD, Wei W, Hu P.
    Clin Exp Med; 2019 May; 19(2):173-181. PubMed ID: 30617865
    [Abstract] [Full Text] [Related]

  • 4. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Nov 27; 17(1):78. PubMed ID: 31775782
    [Abstract] [Full Text] [Related]

  • 6. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
    Lu Y, Chen T, Wen Y, Si F, Wu X, Yang Y.
    BMC Pediatr; 2021 Sep 16; 21(1):406. PubMed ID: 34530763
    [Abstract] [Full Text] [Related]

  • 7. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov 16; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 8. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 21; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 10. Procalcitonin as a Biomarker of Unresponsiveness to Intravenous Immunoglobulin for Kawasaki Disease.
    Nakamura N, Muto T, Masuda Y, Numoto S, Kodama S, Miyamoto R, Miyata K, Hayakawa T, Mori H, Kuroyanagi Y, Akaihata M, Iwayama H, Kurahashi H, Shimomura Y, Nagai T, Hori T, Agata H, Okumura A.
    Pediatr Infect Dis J; 2020 Sep 21; 39(9):857-861. PubMed ID: 32433223
    [Abstract] [Full Text] [Related]

  • 11. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
    Ann Med; 2023 Sep 21; 55(2):2264315. PubMed ID: 37870383
    [Abstract] [Full Text] [Related]

  • 12. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 21; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 13. The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.
    Samadli S, Liu FF, Mammadov G, Wang JJ, Liu HH, Wu YF, Luo HH, Wu Y, Chen WX, Zhang DD, Wei W, Hu P.
    Pediatr Rheumatol Online J; 2019 Jul 31; 17(1):53. PubMed ID: 31366406
    [Abstract] [Full Text] [Related]

  • 14. Platelet-Derived Microparticles: A New Index of Monitoring Platelet Activation and Inflammation in Kawasaki Disease.
    Jin J, Wang J, Lu Y, Fan Z, Huang N, Ma L, Yu H.
    Indian J Pediatr; 2019 Mar 31; 86(3):250-255. PubMed ID: 30159809
    [Abstract] [Full Text] [Related]

  • 15. The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease.
    Wang QQ, Zheng LY, Zhao S.
    Turk J Pediatr; 2023 Mar 31; 65(4):640-649. PubMed ID: 37661679
    [Abstract] [Full Text] [Related]

  • 16. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul 31; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 17. Analysis of Age, Sex, Lack of Response to Intravenous Immunoglobulin, and Development of Coronary Artery Abnormalities in Children With Kawasaki Disease in Japan.
    Takekoshi N, Kitano N, Takeuchi T, Suenaga T, Kakimoto N, Suzuki T, Kada TT, Shibuta S, Tachibana S, Murayama Y, Yamaga H, Suzuki H.
    JAMA Netw Open; 2022 Jun 01; 5(6):e2216642. PubMed ID: 35696166
    [Abstract] [Full Text] [Related]

  • 18. Ultrasound evaluation of endothelial dysfunction in immunoglobulin-resistant children with acute Kawasaki disease.
    Wen Y, Yang Y, Wen Y, Xi J, Chen T, Lu Y, Wang L, Liu Y, Si F.
    Clin Rheumatol; 2022 Dec 01; 41(12):3797-3805. PubMed ID: 35982351
    [Abstract] [Full Text] [Related]

  • 19. Relationship between post-IVIG IgG levels and clinical outcomes in Kawasaki disease patients: new insight into the mechanism of action of IVIG.
    Goto R, Inuzuka R, Shindo T, Namai Y, Oda Y, Harita Y, Oka A.
    Clin Rheumatol; 2020 Dec 01; 39(12):3747-3755. PubMed ID: 32458247
    [Abstract] [Full Text] [Related]

  • 20. Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children.
    Lee NH, Choi HJ, Kim YH.
    Korean J Pediatr; 2017 Apr 01; 60(4):112-117. PubMed ID: 28461824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.